Risk Factors for Tumor Lysis Syndrome (TLS) In Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Cyclin Dependent Kinase Inhibitor, Flavopiridol

被引：0
|
作者：
Blum, Kristie A. [1 ]
Ruppert, Amy S. [1 ]
Woyach, Jennifer A. [1 ]
Jones, Jeffrey A. [1 ]
Andritsos, Leslie [1 ]
Flynn, Joseph M. [1 ]
Rovin, Brad [1 ]
Villalona-Calero, Miguel [1 ]
Ji, Jia [1 ]
Phelps, Mitchell [1 ]
Johnson, Amy J. [1 ]
Greyer, Michael R. [1 ]
Byrd, John C. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：596 / 597
页数：2
相关论文
共 50 条
  • [1] Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol
    K A Blum
    A S Ruppert
    J A Woyach
    J A Jones
    L Andritsos
    J M Flynn
    B Rovin
    M Villalona-Calero
    J Ji
    M Phelps
    A J Johnson
    M R Grever
    J C Byrd
    Leukemia, 2011, 25 : 1444 - 1451
  • [2] Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol
    Blum, K. A.
    Ruppert, A. S.
    Woyach, J. A.
    Jones, J. A.
    Andritsos, L.
    Flynn, J. M.
    Rovin, B.
    Villalona-Calero, M.
    Ji, J.
    Phelps, M.
    Johnson, A. J.
    Grever, M. R.
    Byrd, J. C.
    LEUKEMIA, 2011, 25 (09) : 1444 - 1451
  • [3] Activity of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed, genetically high risk chronic lymphocytic leukemia (CLL)
    Lin, T. S.
    Andritsos, L. A.
    Jones, J. A.
    Fischer, B.
    Heerema, N. A.
    Blum, K. A.
    Flynn, J. M.
    Moran, M. E.
    Phelps, M. A.
    Grever, M. R.
    Byrd, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia Patients Treated with Flavopiridol
    Ji, Jia
    Mould, Diane R.
    Blum, Kristie A.
    Ruppert, Amy S.
    Poi, Ming
    Zhao, Yuan
    Johnson, Amy J.
    Byrd, John C.
    Grever, Michael R.
    Phelps, Mitch A.
    CLINICAL CANCER RESEARCH, 2013, 19 (05) : 1269 - 1280
  • [5] TUMOR LYSIS SYNDROME (TLS) IN PATIENTS RECEIVING FLUDARABINE (F) FOR CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    FRAME, JN
    SORENSEN, JM
    QASHU, N
    VENA, D
    CHRISTIAN, M
    CHUN, HG
    CHESON, BD
    BLOOD, 1993, 82 (10) : A139 - A139
  • [6] PSEUDOHYPOPHOSPHATEMIA CAUSED BY SEVERE LEUKOCYTOSIS IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND TUMOR LYSIS SYNDROME (TLS)
    Jafarizade, Mehrian
    Duffy, Margaret
    Chong, Grace
    Guzzo, Joseph
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 589 - 589
  • [7] REDUCTION OF TUMOR LYSIS SYNDROME (TLS) RISK IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS TREATED WITH ABT-199 (GDC-0199): RESULTS OF MODIFICATIONS TO DOSING SCHEDULE AND TLS PROPHYLAXIS
    Seymour, J.
    Roberts, A.
    Stilgenbauer, S.
    Gressick, L. A.
    Rudersdorf, N. K.
    Busman, T.
    Munasinghe, W.
    Wong, S.
    Desai, M.
    Best, A. E.
    Cerri, E.
    Enschede, S. H.
    Humerickhouse, R. A.
    HAEMATOLOGICA, 2014, 99 : 321 - 321
  • [8] Incidence and risk of tumor lysis syndrome in patients with chronic lymphocytic leukemia (CLL) treated with venetoclax outside the context of a clinical trial
    Koehler, Amber
    Leung, Nelson
    Finnes, Heidi
    Call, Timothy
    Rabe, Kari
    Achenbach, Sara
    Ding, Wei
    Kenderian, Saad
    Leis, Jose
    Muchtar, Eli
    Hayman, Suzanne
    Fonder, Amie
    Schwager, Susan
    Slager, Susan
    Kay, Neil
    Parikh, Sameer
    LEUKEMIA & LYMPHOMA, 2020, 61 : 231 - 233
  • [9] Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice
    Koehler, Amber B.
    Leung, Nelson
    Call, Timothy G.
    Rabe, Kari G.
    Achenbach, Sara J.
    Ding, Wei
    Kenderian, Saad S.
    Leis, Jose F.
    Wang, Yucai
    Muchtar, Eli
    Hayman, Suzanne R.
    Hampel, Paul J.
    Finnes, Heidi D.
    Schwager, Susan M.
    Slager, Susan L.
    Kay, Neil E.
    Parikh, Sameer A.
    LEUKEMIA & LYMPHOMA, 2020, 61 (10) : 2383 - 2388
  • [10] Successful management (Mgt) of hyperkalemia associated with tumor lysis syndrome (TLS) in refractory chronic lymphocytic leukemia (CLL) patients (pts) receiving flavopiridol on an active pharmacologically derived schedule.
    Moran, ME
    Fischer, B
    Broering, S
    Blum, KA
    Lin, TS
    Byrd, JC
    Grever, MR
    Brooker-McEldowney, M
    BLOOD, 2005, 106 (11) : 600A - 601A
12345